1X, Unitree and the Humanoid Developer-Market Gap

1X’s NEO push is starting to look like an attempt to build a Western developer-access platform for humanoids.

The company is still framing NEO as a consumer home robot. Early Access is priced at $20,000, first U.S. deliveries are planned for 2026, and a $499/month subscription model is expected to follow later. But the practical sequencing matters, 1X says current NEOs coming off the line are being prioritised for its internal team to accelerate development and home testing, while the company ramps production from an initial 10,000-unit annual capacity toward 100,000+ units per year by the end of 2027.

Getting robots safe, useful and affordable enough for ordinary homes is still a hard challenge. But there is already an important customer base in developers, researchers, universities, labs and early-access buyers. Unitree’s STAR Market materials show that dynamic clearly. The company reportedly shipped more than 5,500 humanoids in 2025, but its humanoid revenue in the first three quarters of the year was still dominated by research and education at 73.6%, with industrial applications at about 9%.

In other words, Unitree sold into the market that actually existed.

That is the gap 1X is now moving toward from the other side with their founder sharing that they are accelerating plans for developer access. Western humanoid companies have mostly kept hardware inside controlled pilots, industrial trials, customer-specific deployments and internal development. That approach makes sense for safety, reliability and enterprise validation. But it leaves relatively few Western humanoid platforms available to the developers and researchers who want hardware in hand now.

Source: 1X

Unitree filled that availability gap. The G1 became visible across labs, developers and early adopters not only because it was technically capable, but because it was accessible: a commercially available humanoid platform that labs, developers and early adopters could actually buy, test and build around.

That availability now has a political dimension. U.S. lawmakers are increasingly treating Chinese humanoid robots as a national-security and industrial-base issue. The concern is not just that Chinese companies are shipping low-cost robots; it is that humanoids could follow the commercial-drone pattern, where DJI became the default platform before U.S. alternatives had comparable scale, distribution or price accessibility.

The policy response creates its own problem. Restricting access to Chinese humanoid platforms before credible Western alternatives are available would leave developers with fewer options, not more. It would also run into a harder supply-chain reality: many Western robotics companies still depend on China-linked manufacturing capacity, components or supplier ecosystems somewhere in the stack.

1X is also trying to address the supply-chain side of the same problem.

At its NEO Factory in Hayward, California, 1X says it designs and manufactures critical NEO components in-house, including motors, batteries, structures, transmission systems, soft goods and sensors. It describes the facility as a vertically integrated high-volume humanoid factory, with internal manufacturing lines, factory software, reliability testing, motor production, battery-pack production, hand assembly and new-product-introduction lines.

That does not mean 1X has solved home autonomy. It does not mean NEO is ready for ordinary mass-market deployment. But it does make the company relevant to a very specific market opening: a lower-cost Western humanoid platform, built with a heavier degree of in-house manufacturing control, arriving at the moment policymakers and developers are both looking for alternatives to Chinese hardware.

That creates a second-order advantage for 1X: hundreds or thousands of developers building on the same platform can become a compounding force in itself.